Contingent Liability :
 
 Bank Guarantees issued are Rs 17.50 lacs of 100% margin.
 
 1 The margin for bank guarantees is shown by the company under the head
 Fixed Deposits.
 
 2 As per approval received from RBI and as per the Technology Transfer
 Agreement Technical know how fees was payable of Rs. 493.22 lac by the
 company in previous year and shown as capital work in progress.
 
 Against this a sum of Rs. 169.83 lac is still payable. The company has
 received a letter from M/s Biocore Medical Technologies, Inc. waiving
 off the payable amount. The company intends to intimate RBI on the
 matter and only then write back the liability.
 
 In view of the letter obtained by the company from M/s Biocore Medical
 Technologies, Inc. the retainable value of the technology is higher
 them its book value as the technology is being used in India and
 Abroad.
 
 3 As per the legal advise obtained by the Company most of unsecured
 loans in the form of fixed deposits and bonds are overdue and barred by
 limitation hence provision of interest is not made.
 
 4 Some of the balances appearing under Sundry Debtors are subject to
 confirmation and reconciliation and consequent adjustments arising out
 there from would be done in the year of reconciliation.  - ''
 
 5 Previous year figures have been reclassified and regrouped wherever
 considered Necessary.
 
 6 Additional information pursuant to part (3) & (4) of part II of
 Schedule VI of Companies Act, 1956 is given below:
 
 7 (a) Segment report is based on business segments. These business
 segments are: 1. Biotech Division 2. IT Enabled Services 3. Others.
 There are no geographical segments.
 
 (b) Segment accounting policies are the same as those used in the
 preparation of the financial statements.
 
 The segments revenue and segment expenses are directly attributable to
 the segments. The assets are not classified into the segments owing to
 the nature of activities.